#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Paraganglion neoplasm Marginal zone lymphoma refractory Candida infection Leiomyosarcoma recurrent Hypoparathyroidism B-cell lymphoma recurrent Hypoxic-ischaemic encephalopathy Glomerulonephritis chronic Adenomatous polyposis coli Encephalitis autoimmune Ventricular tachycardia Astrocytoma Porphyria non-acute Leiomyosarcoma Paraneoplastic neurological syndrome More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Chordoma – Life with Disease Rhabdomyosarcoma – Trials in Disease Mantle cell lymphoma refractory – Life with Disease Metachromatic leukodystrophy – Basic Information Pleural mesothelioma malignant Osteosarcoma – Trials in Disease Netherton’s syndrome – Diagnostics Angelman’s syndrome – Diagnostics Alternating hemiplegia of childhood – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ursodoxicoltaurine Aztreonam Cl-Ad-Msc-002 Phenazone ANHYDROUS CALCIUM FOLINATE Ucp2 Elafibranor IMELASOMERAN Fluciclovine (18F) Carvedilol Romosozumab ABY-271 Esk-001 SIPAVIBART Candesartan Cilexetil Tub-040 MAGNESIUM CARBONATE HEAVY ARTICAINE HYDROCHLORIDE Ixazomib Islatravir More therapies…

    Learn about Your Condition

    Bronchopulmonary aspergillosis Laparoscopic surgery Peripheral ischaemia White matter lesion Body mass index increased Caesarean section Pseudoxanthoma elasticum Anal fistula Leiomyosarcoma metastatic Thrombolysis Alport's syndrome Pulmonary hypertension Thyroid cancer Oral lichen planus Bladder cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Regional Du Cancer De Montpellier

Institut Regional Du Cancer De Montpellier

208 Avenue Des Apothicaires, Montpellier, 34298, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effectiveness of Vepdegestrant and PF-07220060 for Adults with ER+/HER2- Advanced or Metastatic Breast Cancer

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Pf-07220060 Monohydrate
    • (3S)-3-[6-[4-[[1-[4-[(1R,2S)-6-Hydroxy-2-Phenyl-1,2,3,4-Tetrahydronaphthalen-1-Yl]Phenyl]Piperidin-4-Yl]Methyl]Piperazin-1-Yl]-3-Oxo-1H-Isoindol-2-Yl]Piperidine-2,6-Dione
    Belgium France Spain

  • Study on the Effectiveness and Safety of L19TNF and Dacarbazine for Patients with Advanced or Metastatic Soft-Tissue Sarcoma After Previous Treatments

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Dacarbazine
    • Onfekafusp Alfa
    France Germany Italy Poland Spain

  • Study on Niraparib for Maintenance Treatment in Patients with Advanced Ovarian Cancer After Initial Chemotherapy Response

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    Belgium Czechia Denmark Finland France Germany +6

  • Study Comparing Selpercatinib with a Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Pembrolizumab
    Belgium France Germany Greece Italy The Netherlands +1

  • Study of Retifanlimab, Carboplatin, and Paclitaxel for Patients with Inoperable or Metastatic Anal Canal Squamous Cell Carcinoma Not Treated with Chemotherapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Retifanlimab
    • Carboplatin
    • Paclitaxel
    Belgium Denmark France Germany Italy Norway +2

  • Study of Trastuzumab Deruxtecan with or without Pertuzumab for Patients with HER2-positive Metastatic Breast Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Docetaxel
    • Paclitaxel
    • Pertuzumab
    Belgium Denmark France Germany Hungary Italy +3

  • A Study of GEN1047 in Patients with Solid Tumors: First Time Use in Humans

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Gen1047
    Belgium Denmark France Italy The Netherlands Poland +1

  • Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with Advanced HER2-Positive Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • HER2 positive breast cancer
    Investigated Drugs:
    • Trastuzumab Emtansine
    • Trastuzumab Deruxtecan
    Belgium France Italy Spain

  • Study of Durvalumab with Chemotherapy and Radiotherapy for Patients with Unresectable Esophageal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • Folinic Acid
    • Durvalumab
    • Fluorouracil
    France

  • Study of Pembrolizumab with Chemotherapy for Patients with Gastric or Gastroesophageal Junction Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Cisplatin
    Belgium Estonia France Germany Italy Latvia +2
Previous Page
1 … 18 19 20 21 22 … 25
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!